Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01303133 · ClinicalTrials.gov registry record
Natural History of Amyloid Deposition in Adults With Down Syndrome
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 81
- Enrollment target
NCT01303133 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 81 participants.
The verdict
NCT01303133 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the presence of amyloid in non-demented/functionally stable adults with DS as a function of age, dividing the sample into amyloid-positive and amyloid-negative groups. We will also obtain baseline cognitive measures across a range of areas that are often affected by AD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2009-08 |
| Est. Completion | 2018-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01303133
The ClinicalTrials.gov registry entry for NCT01303133 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01303133 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01303133 about?
NCT01303133 is a clinical study titled "Natural History of Amyloid Deposition in Adults With Down Syndrome". The primary objective of this study is to assess the presence of amyloid in non-demented/functionally stable adults with DS as a function of age, dividing the sample into amyloid-positive and amyloid-negative groups. We will also obtain baseline cognitive measures across a range of areas that are of...
What is the current status of trial NCT01303133?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2009-08. Estimated completion is 2018-03-31.
Who is sponsoring clinical trial NCT01303133?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.